UnivIS
Informationssystem der Universität Kiel © Config eG 
Semester: SS 2024 

Pieters R ; Schrappe, Martin ; De Lorenzo P ; Hann I ; De Rossi G ; Felice M ; Hovi L ; LeBlanc T ; Szczepanski T ; Ferster A ; Janka G, Rubnitz J ; Silverman L ; Stary J ; Campbell M ; Li CK ; Mann G ; Suppiah R ; Biondi A ; Vora A ; Valsecchi MG:
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. .
In: Lancet 370 (2007), Nr. 9583, S. 240-250

Krappmann P ; Paulides M ; Stöhr W ; Ittner E, ; Plattig B ; Nickel P ; Lackner H ; Schrappe, Martin ; Janka G ; Beck JD ; Langer T:
Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up. .
In: Pediatr Hematol Oncol 24 (2007), Nr. 2, S. 101-109

Mann G ; Attarbaschi A ; Burkhardt, Birgit ; Niggli F ; Klapper W ; Ludwig WD ; Schrappe, Martin ; Zimmermann M ; Gadner H, ; Reiter A ; Berlin-Frankfurt-Münster Group:
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma. .
In: Br J Haematol 138 (2007), Nr. 3, S. 443-449

Cario, Gunnar ; Izraeli S ; Teichert A ; Rhein P ; Skokowa J ; Möricke, Anja ; Zimmermann M ; Schrauder, Andre ; Karawajew L ; Ludwig WD ; Welte K ; Schünemann HJ ; Schlegelberger B ; Schrappe, Martin ; Stanulla, Martin:
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS .
In: J Clin Oncol 25 (2007), Nr. 30, S. 4813-4820

Jansen MW ; Corral L ; van der Velden VH ; Panzer-Grumayer R ; Schrappe, Martin ; Schrauder, Andre ; Marschalek R ; Meyer C ; den Boer ML ; Hop WJ ; Valsecchi MG ; Basso G ; Biondi A ; Pieters R ; van Dongen JJ:
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. .
In: Leukemia (2007),

Kager L ; Lion T ; Attarbaschi A ; Koenig M ; Strehl S ; Haas OA ; Dworzak MN ; Schrappe, Martin ; Gadner H ; Mann G ; Austrian BFM Study Group:
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children. .
In: Haematologica 92 (2007), Nr. 11, S. 1561-4.

Stanulla, Martin ; Cario, Gunnar ; Meissner, Barbara ; Schrauder, Andre ; Möricke, Anja ; Riehm H ; Schrappe, Martin:
Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group. .
In: Blood Cells Mol Dis 39 (2007), Nr. 2, S. 160-163

Bornhauser BC ; Bonapace L ; Lindholm D ; Martinez R ; Cario, Gunnar ; Schrappe, Martin ; Niggli FK ; Schäfer BW ; Bourquin JP:
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway. .
In: Blood 110 (2007), Nr. 6, S. 2084-2091

Nachman JB ; Heerema NA, ; Sather H, ; Camitta B ; Forestier E ; Harrison CJ ; Dastugue N ; Schrappe, Martin ; Pui CH ; Basso G ; Silverman LB ; Janka-Schaub GE:
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. .
In: Blood 110 (2007), Nr. 4, S. 1112-1115

Conter V ; Valsecchi MG ; Silvestri D ; Campbell M ; Dibar E ; Magyarosy E ; Gadner H ; Stary J ; Benoit Y ; Zimmermann M ; Reiter A ; Riehm H ; Masera G ; Schrappe, Martin:
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial .
In: Lancet 369 (2007), Nr. 9556, S. 123-31

Stanulla, Martin ; Dynybil C ; Bartels DB ; Dördelmann M ; Löning L ; Claviez, Alexander ; Schrappe, Martin ; ALL-BFM study group:
The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group. .
In: Haematologica 92 (2007), Nr. 11, S. 1581-82

Breit S ; Stanulla M ; Flohr T ; Schrappe, Martin ; Ludwig WD ; Tolle G ; Happich M ; Muckenthaler MU ; Kulozik AE:
Activating NOTCH1 mutations predict favorable early treatment response and long term outcome in child-hood precursor T-cell lymphoblastic leukemia. .
In: Blood. 2006 108 (2006), Nr. 4, S. 1151-7

Staal FJ ; Cario, Gunnar ; Cazzaniga G ; Haferlach T ; Heuser M ; Hofmann WK ; Mills K ; Schrappe, Martin ; Stanulla M ; Wingen LU ; van Dongen JJ ; Schlegelberger B:
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks .
In: Leukemia. 20 (2006), Nr. 8, S. 1385-92

Meyer LH, , , , , . ; Karawajew L ; Schrappe, Martin ; Ludwig WD ; Debatin KM ; Stahnke K:
Cytochrome c-related caspase-3 activation determines treatment response and relapse in childhood precursor B-cell ALL. .
In: Blood 107 (2006), Nr. 11, S. 4524-31

Maecker B ; Mougiakakos D ; Zimmermann M ; Behrens M ; Hollander S ; Schrauder, Andre ; Schrappe, Martin ; Welte K ; Klein C:
Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients. .
In: Leukemia 20 (2006), Nr. 4, S. 645-9

Gast A ; Bermejo JL ; Flohr, Thomas ; Stanulla M ; Burwinkel B ; Schrappe, Martin ; Bartram CR ; Hemminki K ; Kumar R:
Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study .
In: Leukemia (2006),

Burkhardt B ; Woessmann W ; Zimmermann M ; Kontny U ; Vormoor J ; Doerffel W ; Mann G ; Henze G ; Niggli F ; Ludwig WD ; Janssen D ; Riehm H ; Schrappe, Martin ; Reiter A:
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. .
In: J Clin Oncol 24 (2006), Nr. 3, S. 491-9

Neudenberger J ; Hotfilder M ; Rosemann A ; Langebrake C ; Reinhardt D ; Pieters R ; Schrauder, Andre ; Schrappe, Martin ; Rottgers S ; Harbott J ; Vormoor J:
Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11). .
In: Br J Haematol. 133 (2006), Nr. 3, S. 337-44

Markus M ; Mann G ; Monschein U ; Lodzinski M ; Gall C ; Flohr T ; Viehmann S ; Langer T ; Schrappe, Martin ; Gadner H ; Haas OA ; Panzer-Grumayer ER:
Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene. .
In: Haematologica 95 (2006), Nr. 5, S. 683-6

Kratz CP ; Boll S ; Kontny U ; Schrappe, Martin ; Niemeyer CM ; Stanulla M:
Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia .
In: Leukemia 20 (2006), Nr. 2, S. 381-3

Möricke, Anja ; Zimmermann M ; Reiter A ; Gadner H ; Odenwald E ; Harbott J ; Ludwig WD ; Riehm H ; Schrappe, Martin:
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. .
In: Klin Padiatr 217 (2006), Nr. 6, S. 310-20

Claviez, Alexander ; Eckert C ; Seeger K, ; Schrauder, Andre ; Schrappe, Martin ; Henze G ; von Stackelberg A:
Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia. .
In: Haematologica 91 (2006), Nr. 2, S. 272-3

Schrauder, Andre ; Reiter A ; Gadner H ; Niethammer D ; Klingebiel T ; Kremens B ; Peters C ; Ebell W ; Zimmermann M ; Niggli F ; Ludwig WD ; Riehm H ; Welte K ; Schrappe, Martin:
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95 .
In: Journal of Clinical Oncology 24 (2006), Nr. 36, S. 5742-9

Gadner H ; Masera G ; Schrappe, Martin ; Eden T ; Benoit Y ; Harrison C ; Nachman J ; Pui CH:
The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005. .
In: Leukemia 20 (2006), Nr. 1, S. 9-17

Meyer C ; Schneider B ; Jakob S ; Strehl S ; Attarbaschi A ; Schnittger S ; Schoch C ; Jansen MW ; van Dongen JJ ; den Boer ML ; Pieters R ; Ennas MG ; Angelucci E ; Koehl U ; Greil J ; Griesinger F ; Zur Stadt U ; Eckert C ; Szczepanski T ; Niggli FK ; Schafer BW ; Kempski H ; Brady HJ ; Zuna J ; Trka J ; Nigro LL ; Biondi A ; Delabesse E ; Macintyre E ; Stanulla M ; Schrappe, Martin ; Haas OA ; Burmeister T ; Dingermann T ; Klingebiel T ; Marschalek R:
The MLL recombinome of acute leukemias. .
In: Leukemia 20 (2006), Nr. 5, S. 777-84

Lauten M ; Schrauder, Andre ; Kardinal C ; Harbott J ; Welte K ; Schlegelberger B ; Schrappe, Martin ; von Neuhoff N:
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance. .
In: Leukemia. 2006 May;20(5):820-6. 20 (2006), Nr. 5, S. 820-6

Schrappe, Martin ; Harbott, J. ; Riehm, H.:
Akute lymphoblastische Leukämien .
In: Gadner, Helmut ; Gaedicke, Gerhard ; Niemeyer, Charlotte ; Ritter, Jörg (Hrsg.) : Pädiatrische Hämatologie und Onkologie.
Heidelberg : Springer, 2005, S. 656-679. - ISBN 3-540-03702-0

Balduzzi A ; Valsecchi MG ; Uderzo C ; De Lorenzo P ; Klingebiel T ; Peters C ; Stary J ; Felice MS ; Magyarosy E ; Conter V ; Reiter A ; Messina C ; Gadner H ; Schrappe, Martin:
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study .
In: Lancet 366 (2005), Nr. 9486, S. 635-42

Einsiedel HG ; von Stackelberg A ; Hartmann R ; Fengler R ; Schrappe, Martin ; Janka-Schaub G ; Mann G ; Hahlen K ; Gobel U ; Klingebiel T ; Ludwig WD ; Henze G:
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87 .
In: J Clin Oncol. 23 (2005), Nr. 31, S. 7942-50

Einsiedel HG ; von Stackelberg A ; Hartmann R ; Fengler R ; Schrappe, Martin ; Janka-Schaub G ; Mann G ; Hahlen K ; Gobel U ; Klingebiel T ; Ludwig WD ; Henze G:
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. .
In: J Clin Oncol 23 (2005), Nr. 31, S. 7942-50

Berthold F ; Boos J ; Burdach S ; Erttmann R ; Henze G ; Hermann J ; Klingebiel T ; Kremens B ; Schilling FH ; Schrappe, Martin ; Simon T ; Hero B:
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial .
In: Lancet Oncol. 6 (2005), Nr. 9, S. 649-58

Möricke, Anja ; Zimmermann M ; Reiter A ; Gadner H ; Odenwald E ; Harbott J ; Ludwig WD ; Riehm H ; Schrappe, Martin:
Prognostic Impact of Age in Children and Adolescents with Acute Lymphoblastic Leukemia: Data from the Trials ALL-BFM 86, 90, and 95 = Prognostic Impact of Age in Children and Adolescents with Acute Lymphoblastic Leukemia: Data from the Trials ALL-BFM 86, 90, and 95 = [Alter als prognostischer Faktor bei Kindern und Jugendlichen mit akuter lymphoblastischer Leukämie : Ergebnisse aus den Therapiestudien ALL-BFM 86, 90 und 95] .
In: Klin Padiatr 217 (2005), Nr. 6, S. 310-320

Gadner H ; Masera G ; Schrappe, Martin ; Eden T ; Benoit Y ; Harrison C ; Nachman J ; Pui CH:
The eighth international childhood acute lymphoblastic leukemia workshop ('Ponte di Legno meeting') report: Vienna, Austria, April 27-28, 2005 .
In: Leukemia 19 (2005), Nr. 11, S. 1-9

Burkhardt B ; Zimmermann M ; Oschlies I ; Niggli F ; Mann G ; Parwaresch R ; Riehm H ; Schrappe, Martin ; Reiter A ; BFM Group:
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence .
In: Br J Haematol. 131 (2005), Nr. 1, S. 39-49

Teuffel O ; Schrauder, Andre ; Sykora KW ; Zimmermann M ; Reiter A ; Welte K ; Schrappe, Martin:
The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia. .
In: Bone Marrow Transplant. 36 (2005), Nr. 2, S. 145-50

Arico M ; Baruchel A ; Bertrand Y ; Biondi A ; Conter V ; Eden T ; Gadner H ; Gaynon P ; Horibe K ; Hunger SP ; Janka-Schaub G ; Masera G ; Nachman J ; Pieters R ; Schrappe, Martin ; Schmiegelow K ; Valsecchi MG ; Pui CH:
The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005 .
In: Leukemia 19 (2005), Nr. 7, S. 1145-52

Stanulla M ; Schaeffeler E ; Flohr T ; Cario, Gunnar ; Schrauder, Andre ; Zimmermann M ; Welte K ; Ludwig WD ; Bartram CR ; Zanger UM ; Eichelbaum M ; Schrappe, Martin ; Schwab M:
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia .
In: JAMA 293 (2005), Nr. 12, S. 1485-9

Machatschek JN ; Schrauder A ; Helm, Frank ; Schrappe, Martin ; Claviez, Alexander:
Acute lymphoblastic leukemia and Klinefelter syndrome in children: two cases and review of the literature .
In: Pediatr Hematol Oncol. 21 (2004), Nr. 7, S. 621-6

UnivIS ist ein Produkt der Config eG, Röttenbach